These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29349060)

  • 21. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
    Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
    Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling.
    Lloyd SA; Loiselle AE; Zhang Y; Donahue HJ
    Bone; 2013 Nov; 57(1):76-83. PubMed ID: 23891909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck.
    Power J; Doube M; van Bezooijen RL; Loveridge N; Reeve J
    Bone; 2012 May; 50(5):1107-14. PubMed ID: 22353552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Osteocyte-PDL Crosstalk in Tooth Movement via SOST/Sclerostin.
    Odagaki N; Ishihara Y; Wang Z; Ei Hsu Hlaing E; Nakamura M; Hoshijima M; Hayano S; Kawanabe N; Kamioka H
    J Dent Res; 2018 Nov; 97(12):1374-1382. PubMed ID: 29863952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free-fall landing and interval running have different effects on trabecular bone mass and microarchitecture, serum osteocalcin, biomechanical properties,
    Boudenot A; Pallu S; Uzbekov R; Dolleans E; Toumi H; Lespessailles E
    Appl Physiol Nutr Metab; 2021 Dec; 46(12):1525-1534. PubMed ID: 34370961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size.
    Kogawa M; Khalid KA; Wijenayaka AR; Ormsby RT; Evdokiou A; Anderson PH; Findlay DM; Atkins GJ
    Am J Physiol Cell Physiol; 2018 Jan; 314(1):C53-C61. PubMed ID: 28978523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mef2c deletion in osteocytes results in increased bone mass.
    Kramer I; Baertschi S; Halleux C; Keller H; Kneissel M
    J Bone Miner Res; 2012 Feb; 27(2):360-73. PubMed ID: 22161640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin deficiency modifies the development of CKD-MBD in mice.
    Kaesler N; Verhulst A; De Maré A; Deck A; Behets GJ; Hyusein A; Evenepoel P; Floege J; Marx N; Babler A; Kramer I; Kneissel M; Kramann R; Weis D; D'Haese PC; Brandenburg VM
    Bone; 2018 Feb; 107():115-123. PubMed ID: 29175269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D osteocyte lacunar morphometric properties and distributions in human femoral cortical bone using synchrotron radiation micro-CT images.
    Dong P; Haupert S; Hesse B; Langer M; Gouttenoire PJ; Bousson V; Peyrin F
    Bone; 2014 Mar; 60():172-85. PubMed ID: 24334189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D assessment of cortical bone porosity and tissue mineral density using high-resolution µCT: effects of resolution and threshold method.
    Palacio-Mancheno PE; Larriera AI; Doty SB; Cardoso L; Fritton SP
    J Bone Miner Res; 2014 Jan; 29(1):142-50. PubMed ID: 23775635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.
    Wein MN; Spatz J; Nishimori S; Doench J; Root D; Babij P; Nagano K; Baron R; Brooks D; Bouxsein M; Pajevic PD; Kronenberg HM
    J Bone Miner Res; 2015 Mar; 30(3):400-11. PubMed ID: 25271055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice.
    Doolittle ML; Saul D; Kaur J; Rowsey JL; Eckhardt B; Vos S; Grain S; Kroupova K; Ruan M; Weivoda M; Oursler MJ; Farr JN; Monroe DG; Khosla S
    J Bone Miner Res; 2022 Sep; 37(9):1750-1760. PubMed ID: 35789113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume.
    Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG
    Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways.
    Bouaziz W; Funck-Brentano T; Lin H; Marty C; Ea HK; Hay E; Cohen-Solal M
    Arthritis Res Ther; 2015 Feb; 17(1):24. PubMed ID: 25656376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerostin vaccination mitigates estrogen deficiency induction of bone mass loss and microstructure deterioration.
    Wang FS; Wu RW; Lain WS; Tsai TC; Chen YS; Sun YC; Ke HJ; Li JC; Hwang J; Ko JY
    Bone; 2018 Jul; 112():24-34. PubMed ID: 29653294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanical load increases in bone formation via a sclerostin-independent pathway.
    Morse A; McDonald MM; Kelly NH; Melville KM; Schindeler A; Kramer I; Kneissel M; van der Meulen MC; Little DG
    J Bone Miner Res; 2014 Nov; 29(11):2456-67. PubMed ID: 24821585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of mechanosensitive sclerostin may accelerate cranial bone growth and regeneration.
    Kang KS; Lastfogel J; Ackerman LL; Jea A; Robling AG; Tholpady SS
    J Neurosurg; 2018 Oct; 129(4):1085-1091. PubMed ID: 29125417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIEG and estrogen modulate SOST expression in the murine skeleton.
    Subramaniam M; Pitel KS; Bruinsma ES; Monroe DG; Hawse JR
    J Cell Physiol; 2018 Apr; 233(4):3540-3551. PubMed ID: 29044507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.